control rules. (2) Lists of permitted and prohibited substances (which may include, without limitation, drugs, medications, naturally occurring substances and synthetically occurring substances) and methods. (3) A prohibition upon the administration of any prohibited or otherwise permitted substance to a covered horse within 24 hours of its next racing start, which shall be effective not later than January 1, 2019. (4) A process for sample collection. (5) Programs for in-competition and out-of-competition testing (including no-advance-notice testing and mandatory reporting of each horse’s location for testing). (6) Testing procedures, standards, and protocols for both in-competition and out-of-competition testing. (7) Laboratory standards for accreditation and testing requirements, procedures, and protocols. (8) The undertaking of investigations at racetrack and non-racetrack facilities related to anti-doping and medication control rule violations. (9) Procedures for investigating, charging, and adjudicating violations and for the enforcement of sanctions for violations. (10) A schedule of sanctions for violations. (11) Disciplinary hearings, which may include binding arbitration, sanctions and research. (12) Management of violation results. (13) Programs relating to anti-doping and medication control research and education. (c) Applicability to covered horses and persons (1) In general The equine horseracing anti-doping and medication control program developed and administered pursuant to subsection (a) shall apply to all covered horses, covered persons, and covered horseraces. (2) Agreement by covered persons As a condition of eligibility to participate in covered horseraces, covered persons shall agree that they and their covered horses shall be bound by the provisions of the horseracing anti-doping and medication control program. (d) Limitation of authority (1) Prospective application The jurisdiction and authority of the Commission and Authority with respect to the horseracing anti-doping and medication